AngioDynamics to Participate in Upcoming Investor Conferences

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management is scheduled to participate in the following upcoming investor conferences:

UBS Global Healthcare Conference
Fireside Chat: Monday, November 9, 2026, from 8:00-8:35 AM ET

Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum
Presentation: Wednesday, November 11, 2026, from 1:00-1:25 PM ET
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261029190648/en/

Investors:
Stephen Trowbridge
Executive Vice President & CFO
518-795-1408
[email protected]

Media:
Saleem Cheeks
Vice President, Communications
518-795-1174
[email protected]

Source: AngioDynamics, Inc.

You May Also Be Interested In

• Daiichi Sankyo Reports Second Quarter Fiscal Year 2026 Financial Results
• Monsanto unanimously wins first Roundup™ trial since U.S. Supreme Court decision
• Solana Price Prediction: The Wait for $200 Puts AlphaPepe Presale Entry Against Another SOL Recovery Bet